Cell-based therapeutics, using cells as therapeutic agents and/or deliver modalities to fight disease, have substantially evolved since the FDA approval of engineered adoptive T cell transfer to treat ...

Please provide your email address to receive an email when new articles are posted on . Higher scores on multiple plant-based diet indices were tied to less weight gain in menopause. Those in the ...

Women battling breast cancer can benefit from a phone-based weight loss program, according to a new study. The Breast Cancer Weight Loss (BWEL) program helped women drop excess pounds, improve their ...

New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone.

WeightWatchers' Core+ program offers personalized weight loss support starting at $20 per month. The program focuses on nutrition, habit-building and community support. Core+ features specialized ...

Even after weight loss, CD4 T cells may retain an obesity-linked inflammatory memory, revealing why immune recovery may lag behind metabolic improvement. Study: DNA methylation-mediated memory of ...

For months, readers emailed Snopes and searched our website asking whether well-known public figures were really endorsing a gelatin — often specifically "pink gelatin" — trick for weight loss. The ...

Chocolate bars made from lab-grown ingredients, rather than cocoa sourced from plantations, are no longer confined to science fiction. They are now a reality, with nearly a dozen such chocolate bars ...

Weight-based pembrolizumab dosing demonstrated comparable effectiveness and safety to fixed dosing in patients with advanced non-small cell lung cancer (NSCLC). In a real-world cohort of 414 patients, ...

We conducted a retrospective cohort study of 414 patients with advanced NSCLC treated with pembrolizumab at a single center between 2016 and 2021. Patients received either fixed-dose or weight-based ...

Among adults with obesity or overweight and related comorbidities, the use of antiobesity medications (AOMs) through a telehealth weight management clinic led to average weight loss of 18.53% at 18 ...

Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...